EksoNR robotic exoskeleton short

Ekso Bionics’ EksoNR robotic exoskeleton is a clinical rehabilitation device designed for overground gait training, according to the company’s product materials. A YouTube short circulating on September 3 highlighted the device in the context of neuro and mobility rehabilitation, focusing on assisted walking practice rather than consumer mobility use. Ekso Bionics says the system is used in rehabilitation institutions under the supervision of a trained physical therapist. The company markets it for patients recovering from conditions that affect walking, including stroke, spinal cord injury, acquired brain injury and multiple sclerosis. ### What exactly is EksoNR being used for in clinics? Ekso Bionics says EksoNR is intended to perform ambulatory functions in rehabilitation institutions, with therapist supervision, for patients in several neurologic populations. The company’s indications page lists multiple sclerosis, acquired brain injury including traumatic brain injury and stroke, and spinal cord injury at levels C7 to L5 as covered populations, subject to specified functional criteria. (eksobionics.com) Sheltering Arms Institute describes EksoNR as an overground exoskeleton that allows patients to bear weight through their legs and walk over ground with robotic assistance. The institute says it is used primarily for patients with neurological injuries to the brain or spinal cord and that the device assists at the hip, knee and ankle while helping maintain upright posture. (eksobionics.com) ### Why does the short focus on stroke, spinal cord injury and complex gait retraining? Ekso Bionics says the device is FDA-cleared for rehabilitation after stroke, spinal cord injury and acquired brain injury, and its marketing materials frame the system around neurologic gait recovery. The company says the exoskeleton is intended to support walking practice and neurological recovery after brain injury, while rehabilitation providers describe it as part of inpatient and outpatient mobility work. (shelteringarmsinstitute.com) Encompass Health says the device is used during inpatient rehabilitation to assist therapists with strengthening, posture, stand time and walking ability. That description aligns with how short-form clinical videos often present the technology: as a tool inside supervised rehab sessions rather than a replacement for conventional therapy. (eksobionics.com) ### What is meant by “stepping dosage” in this context? A 2026 study in *Spinal Cord* examined dose-dependent effects of overground exoskeleton-assisted gait training in people with spinal cord injury, reflecting the broader rehabilitation interest in how many repetitions and how much walking practice a patient can complete. The study’s framing supports why clinicians and device makers emphasize assisted stepping volume when discussing robotic gait systems. (encompasshealth.com) A separate article in the *Archives of Physical Medicine and Rehabilitation* reported on overground robotic exoskeleton gait training after incomplete spinal cord injury and compared it with usual-care gait training. Another recent clinical-delivery paper said overground exoskeleton gait training has been shown to be feasible across inpatient and outpatient rehabilitation settings. (nature.com) ### Does the device replace therapists or standard rehab? Ekso Bionics says EksoNR is used under the supervision of a trained physical therapist, and its product page says the system is meant to reduce the physical demands of gait training while allowing clinicians to focus on patient care. The company presents the device as a rehabilitation tool that can be integrated into therapy rather than a stand-alone treatment. (sciencedirect.com) Sheltering Arms Institute and Encompass Health both describe EksoNR as one element of rehabilitation programs aimed at walking, posture and mobility. Those provider descriptions match the way hospitals present robotics in practice: as part of broader plans that also include balance work, transfers, strengthening and functional training. (eksobionics.com) ### Where can readers verify the device’s current status? Ekso Bionics’ indications page and product page list the current U.S. use cases and supervision requirements for EksoNR. FDA clearance details for the device also appear in publicly indexed regulatory records, including a 510(k) listing tied to K220988 and earlier company disclosures on acquired brain injury clearance in June 2020. (eksobionics.com) (shelteringarmsinstitute.com)